Acumen Pharmaceuticals, Inc. (ABOS) › Cash & EquivalentsAcumen Pharmaceuticals, Inc. (ABOS) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2019: $6.55M2020: $43.78M2021: $122.16M2022: $130.10M2023: $66.89M2024: $35.63M2025: $53.99M$53.99M2019Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$53.99M+51.5%2024$35.63M-46.7%2023$66.89M-48.6%2022$130.10M+6.5%2021$122.16M+179.1%2020$43.78M+568.1%2019$6.55M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share